Viewing Study NCT00278057



Ignite Creation Date: 2024-05-05 @ 4:37 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00278057
Status: COMPLETED
Last Update Posted: 2006-01-18
First Post: 2006-01-16

Brief Title: STUDY OF GLUCOSE IN DIALYSIS WATER WITH REGARD TO BLOOD PRESSURE AND QUALITY OF LIFE
Sponsor: Regional Hospital Holstebro
Organization: Regional Hospital Holstebro

Study Overview

Official Title: PHASE 4 STUDY OT THE EFFECT OF GLUCOSE ADDED TO THE DIALYSIS FLUID ON BLOOD PRESSURE BLOOD GLUCOSE AND QUALITY OF LIFE IN HEMODIALYSIS PATIENTS
Status: COMPLETED
Status Verified Date: 2006-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: We wanted to test the hypotheses that blood pressure level was lower that the variability of blood pressure and blood glucose was reduced and that quality of life was improved when glucose was added to the dialysis fluid
Detailed Description: The purpose of the study was to determine the effect of glucose added to the dialysis fluid on 1blood pressure and variation in blood pressure 2blood glucose and variation in blood glucose and 3quality of life in patients treated with chronic maintenance hemodialysis in a randomized placebo-controlled unblinded cross-over study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None